ESMO Open
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ESMO Open
Sep 21, 2024, 09:35 |
Blog
Elisa Agostinetto: Characteristics and clinical outcomes of breast cancer
Elisa Agostinetto shared a post on X, about recent paper published in ESMO Open: Characteristics…
Sep 14, 2024, 09:44 |
Societies
Key factors in promoting Professional Wellbeing of the Healthcare Workforce - ESMO
European Society for Medical Oncology(ESMO) shared a post on LinkedIn: "What are the key factors in…
Sep 12, 2024, 10:29 |
Career
John Haanen Honored with 2024 ESMO Lifetime Achievement Award
John Haanen was recently awarded the 2024 ESMO Lifetime Achievement Award. John B.A.G. Haanen is…
Sep 9, 2024, 14:16 |
Blog
Tom Powles: Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions
Tom Powles shared a post on X, about recent paper published in ESMO Open: The…
Sep 6, 2024, 11:25 |
Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
Sep 4, 2024, 05:57 |
Insight
Maria Lucia Reale: MET exon 14 skipping mutations in NSCLC
Maria Lucia Reale, Medical Oncologist at Vito Fazzi Hospital Company, shared on X: “Just out…
Sep 2, 2024, 17:22 |
Insight
Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer
Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…
Sep 1, 2024, 15:03 |
Blog
ESMO is seeking a new Editor-in-Chief to ESMO Open
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "ESMO is seeking…
Aug 28, 2024, 14:41 |
Insight
Targeting HER2-low gastric cancer, summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article…
Aug 24, 2024, 13:01 |
Insight
Gabor Liposits: Geriatric assessment and management in older adults with cancer
Gabor Liposits, Senior consultant of Clinical Oncology at Regionshospitalet Gødstrup, shared on LinkedIn: "Hot of…
Aug 17, 2024, 19:56 |
Insight
Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara Üniversitesi Tıp Fakültesi, a post on X: "Oncotype…
Aug 12, 2024, 12:24 |
Blog
Adjuvant chemotherapy schedules for breast cancer according to BMI
Marco Tagliamento, Medical oncologist at Ospedale Policlinico San Martino, shared a post on X: "Congrats…
Aug 8, 2024, 05:32 |
Blog
Vivek Subbiah: Embracing novel technologies for a progressive health system
Vivek Subbiah shared a post on LinkedIn: "Hot off the press Special communication article just…
Jul 11, 2024, 14:28 |
Blog
Alice Avancini: Exercise promotion in cancer by the oncologists
Kathryn Schmitz, Oncology researcher at Pitt’s School of Medicine and the director of UPMC Hillman’s…
Jul 4, 2024, 14:15 |
Insight
Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment
ESMO Open shared a post on X: "Hot off the press: Francesco Schettini et al.…
Jul 2, 2024, 15:04 |
Blog
Francesco Schettini: Molecular changes induced by neoadjuvant CT and ET in breast cancer
Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona and Postdoc…
Jun 26, 2024, 15:13 |
Blog
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X: "Our new…
Jun 23, 2024, 11:13 |
Blog
The new Impact Factor for ESMO Open has just been released
ESMO Open shared on X: "The new Impact Factor for ESMO Open has just been…
Jun 19, 2024, 12:19 |
Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 15, 2024, 16:02 |
Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 14, 2024, 16:10 |
Insight
Ghassan Abou-Alfa on a paper by Arndt Vogel et al.
Ghassan Abou-Alfa, a Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on…
Jun 10, 2024, 10:08 |
Societies
Vivek Subbiah: I endorse Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "The elections for the ESMO President 2027-2028 are happening, its…
Jun 9, 2024, 01:38 |
Insight
Stephen V Liu reflects on OS from PACIFIC-R
Stephen V Liu shared the following insight on X: "OS from PACIFIC-R: real-world outcomes with…
Jun 7, 2024, 11:07 |
Blog
Paolo Tarantino: Grateful to be part of the ESMO Open team
Paolo Tarantino shared a post by Giuseppe Curigliano on LinkedIn: "Grateful to be part of the…
May 25, 2024, 07:41 |
Insight
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections!
Paolo Tarantino shared on LinkedIn: “I’m extremely excited to support Giuseppe Curigliano for the next…
May 24, 2024, 00:42 |
Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
May 23, 2024, 14:29 |
Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
May 15, 2024, 04:35 |
Blog
Paolo Tarantino: A pleasure to co-host the latest ESMO Open podcast with Giuseppe Curigliano
Paolo Tarantino shared a post by ESMO - European Society for Medical Oncology on LinkedIn, adding:…
May 7, 2024, 06:28 |
Insight
Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn: "The long and…
May 6, 2024, 13:19 |
Blog
Jon Lim: Some real challenges faced by oncologists in pursuing postgrad degrees
Jon Lim, Medical Oncologist and Postdoctoral Clinical Fellow at The Francis Crick Institute, posted on…
Apr 28, 2024, 16:53 |
Blog
Paolo Tarantino: Unmissable editorial on the current status and next steps for studying and treating brain metastases in breast oncology
Paolo Tarantino shared a post by ESMO Open, on X: "Unmissable editorial on the current status…
Apr 28, 2024, 12:38 |
Insight
Piotr Wysocki: Combined treatment (TKI+ICI) does not benefit favorable-risk mRCC patients
Piotr Wysocki recently shared on LinkedIn: "For several years, combined therapy based on the administration of…
Apr 25, 2024, 00:51 |
Insight
New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…
Apr 19, 2024, 06:47 |
Positive
Editor Spotlight this week is Susana Banerjee - ESMO Open
ESMO Open shared on X: “Our Editor Spotlight this week is Susana Banerjee, ESMO Open…
Apr 17, 2024, 13:11 |
Insight
New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis
New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…
Apr 16, 2024, 00:17 |
Blog
Paolo Tarantino: We review best practices and future perspectives for the identification of patients with HER2-low Breast Cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "In our latest…
Apr 11, 2024, 17:37 |
Societies
Our Editor Spotlight this week is John B. Haanen, editor for immunotherapy - ESMO Open
ESMO Open shared a post on X: “Our Editor Spotlight this week is John B.…
Mar 31, 2024, 14:36 |
Insight
Nazik Hammad: First systematic review on cancer workforce
Nazik Hammad posted on LinkedIn: "1st systematic review on cancer workforce. 1st lesson: quantity is not…
Mar 23, 2024, 14:45 |
Insight
Article summaries by Erman Akkus: BMI and cancer prognosis and billiary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter: 1. ''BMI, weight…
Mar 21, 2024, 10:54 |
Insight
The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open
ESMO Open posted on X: "Hot off the press: among 757 patients with early HER2+ breast…
Mar 13, 2024, 23:46 |
Blog
Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on LinkedIn: “Our meta-analysis looking…
Mar 8, 2024, 19:21 |
Societies
Our Editor Spotlight this week is Chiara Cremolini - ESMO Open
ESMO Open Journal announced on their X/Twitter page: "Our Editor Spotlight this week is Chiara…
Feb 26, 2024, 10:49 |
Blog
Our Editor Spotlight this week is Solange Peters - ESMO Open
The Open Access journal of ESMO shared on their X/Twitter: ''Our Editor Spotlight this week is…
Feb 8, 2024, 17:54 |
Insight
Paolo Tarantino: Few treatments in oncology allow to achieve more than 50% intracranial response rates, with durable efficacy
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared ESMO Open's post on X/Twitter, adding: "One…
Nov 19, 2023, 00:17 |
Blog
Stephanie Graff: Another brilliant editor-in-chief announcement from The European Society for Medical Oncology, this time for ESMO Open
Stephanie Graff shared the following on Twitter: “Another brilliant editor-in-chief announcement from The European Society…
Nov 11, 2023, 12:49 |
Blog
Benedikt Westphalen: CUPISCO is out in ESMO Open
Benedikt Westphalen, Medical Lead of Precision Oncology at the Cancer Center Munich, shared on LinkedIn:…
Sep 7, 2023, 19:38 |
Insight
Jarushka Naidoo: The secret to a long life as a clinician scientist is the same as a long marriage.
Quoting Jarushka Naidoo, a Professor of Medical Oncology at the Royal College of Surgeons in Ireland…
All:
47
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube